Cloud-Clone Multi-Application Antibodies: Reliable Partners for Research and Diagnostic Fields

High-Specificity, Multi-Platform Validated Antibody Portfolio for Global Life Science and IVD Development

HUSTON, TX, UNITED STATES, August 19, 2026 /EINPresswire.com/ -- With the continuous advancement of life-science research and in-vitro diagnostic (IVD) raw material development, high-quality antibodies suitable for diverse scenarios have become core cornerstones for research breakthroughs and clinical testing. Drawing on two decades of accumulated experience in antibody R&D and manufacturing, Cloud-Clone has built an end-to-end one-stop antibody development platform covering polyclonal, monoclonal and recombinant antibodies. Powered by self-owned core technologies, strict quality-control systems and a comprehensive product portfolio, Cloud-Clone delivers stable and efficient antibody solutions for researchers and industrial partners across the globe.

Full-chain In-house R&D to Consolidate Quality Foundation
Cloud-Clone carries out 100% in-house R&D and production. The whole workflow, from antigen design and antibody generation to finished-product validation, is independently controlled to fully guarantee supply stability and batch-to-batch consistency. By deploying innovative manufacturing technologies including proprietary polymer adjuvants, nano-emulsification and recombinant antibody techniques, the company minimizes batch-to-batch variations and ensures reliable experimental performance of every antibody.
Meanwhile, Cloud-Clone adheres to international quality management standards and holds dual ISO 9001 and ISO 13485 certifications. A three-level quality-control procedure is implemented for raw materials, intermediates and finished products to guarantee consistency and stability of each batch, building solid quality safeguards for research experiments and diagnostic applications.

Large-scale Product Library Covering Multiple Species and Targets
To satisfy diversified demands from life-science research, Cloud-Clone has established a library with over 27 000 high-specificity antibodies covering human, mouse, rat, rabbit, pig, bovine, goat and other species. It meets antibody-related R&D and application requirements for different organisms and targets.
Whether for common targets in basic research or specific biomarkers for diagnostic development, Cloud-Clone provides matching antibody reagents without lengthy custom development cycles, accelerating progress for both research and industrial projects.
Multi-scenario Validated Products to Meet Full-spectrum Experimental Demands
Cloud-Clone antibodies are validated across multiple technical platforms including WB, ELISA, IHC, IF, FCM and IP. Their specificity is further verified with the gold-standard KO knockout validation, realizing “one antibody for multiple applications”, which effectively cuts experimental costs and optimizes workflow efficiency.

Representative flagship products are shown below:
- TUBb Monoclonal Antibody (CAB870Hu22): performs steadily in Western Blot, IHC-P and IF assays, generating clear specific bands and localization signals in human-derived cells and rat tissues.
- PCNA Monoclonal Antibody (CAA591Hu22): compatible with sample detection across multiple species and delivers outstanding staining results in IHC tests on rat brain and testis tissues.
- GAL1 Polyclonal Antibody (PAA321Hu01), OTUB1 Polyclonal Antibody (PAL838Hu01) and other products have passed multiple validations via WB, IHC, IF and FCM, delivering stable performance across different samples and platforms.
In addition, Cloud-Clone offers more than one-hundred multi-application antibodies such as CK18, IGFBP2, NQO1 and CDKN2A. These products cover hot-research topics including cell proliferation, tumour biomarkers, metabolic regulation and immune modulation, and are fully adapted to basic research, drug development and IVD raw-material development.

Global Acknowledgement and Extensive Citations in High-impact Journals
Superior product performance has earned broad recognition within the global scientific community. Up to now, Cloud-Clone antibodies have been cited more than 42 000 times in SCI-indexed publications. Among them, over 350 research papers are published in top-tier journals including Nature, Science and Cell, spanning tumour research, neuroscience, molecular biology, clinical medicine and other disciplines. They serve as dependable experimental tools for high-impact studies.
Ranging from routine-target antibodies such as CD45 and ACTB to specialized biomarker antibodies like GAL8 and MST, Cloud-Clone products continuously support global research teams to achieve important scientific discoveries.

One-stop Custom Services for Individualized Requirements
Apart from off-the-shelf standard products, Cloud-Clone’s integrated antibody platform also supports custom antibody generation for multiple species and targets. It delivers full-cycle services from antigen design to finished-product validation according to personalized demands of research and industry partners. The services are flexibly adapted to special scenarios such as IVD raw-material development and antibody development for unique targets.
With twenty-year continuous dedication, Cloud-Clone adheres to the core principle of “technology-driven innovation, quality-oriented excellence”. High-quality antibody products bridge research and real-world applications and help life-science research break new boundaries. Moving forward, Cloud-Clone will keep optimizing its technical platforms and expanding product portfolios. It will deliver more stable, efficient and well-adapted antibody solutions for global research and diagnostic sectors, and grow into a trusted long-term partner for scientists and industry stakeholders.

About Cloud-Clone Corp.
Cloud-Clone Corp. is dedicated to the development and production of high-quality immunoassay reagents and detection solutions. With a focus on antibody engineering, multiplex assay development, and cross-platform compatibility, the company provides research tools designed to support precision medicine and advanced biomedical investigation globally. Our core products and services include the research and development of proteins, antibodies, ELISA kits, primary cells, and multiplex cytokine assay kits, as well as professional CRO services to fully meet the diverse needs of biomedical research and related fields.
For more information about Cloud-Clone Corp, visit www.cloud-clone.com.

CLOUD-CLONE CORP.(CCC)
Tel: 001-832-538-0970, 0086-27-8425-9552
Email: mail@cloud-clone.com, sales@cloud-clone.us

Visit us on social media:
LinkedIn: https://www.linkedin.com/company/cloud-clone-corp/
Instagram: https://www.instagram.com/cloudclonecorp2023/
TickTok: https://www.tiktok.com/@cloudclonecorp2026

SuKi Duan
CLOUD-CLONE CORP.WUHAN
email us here
Visit us on social media:
LinkedIn
Instagram
TikTok
X